We conducted a post hoc analysis of the Vitamin Intervention for Stroke Prevention ( VISP ) trial , a randomized controlled trial evaluating treatment with high - versus low-dose B vitamin therapy for secondary prevention of vascular events among stroke survivors with elevated homocysteine .